ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

j-c health care ltd - infliximab 100 mg/vial - powder for concentrate for infusion - infliximab - - adult :crohn's disease: treatment of severe active crohn's disease in patients who have not responded despite of a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant. treatment of fistulising crohn's disease in patients who have not responded despite of a full and adequate course of therapy with conventional treatment. -paediatric crohn's disease: remicade is indicated for: treatment of severe active crohn's disease in paediatric patients aged 6 to 17 years who have not responded to conventional therapy including a corticosteroid an immunomodulator and primary nutrition therapy or who are intolerant to or have contraindications for such therapies. remicade has been studied only in combination with conventional immunosuppressive therapy -ankylosing spondylitis: remicade is indicated for: treatment of ankylosing spondylitis in patients who have severe axial symptoms elevated serological markers of inflammatory activity and who have responded inadequately to conventional ther

ישראל - עברית - Ministry of Health

j-c health care ltd - infliximab - אבקה להכנת תרכיז לאינפוזיה - infliximab 100.0 mg/vial - infliximab - infliximab - - adult :crohn's disease: treatment of severe active crohn's disease in patients who have not responded despite of a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant. treatment of fistulising crohn's disease in patients who have not responded despite of a full and adequate course of therapy with conventional treatment. -paediatric crohn's disease: remicade is indicated for: treatment of severe active crohn's disease in paediatric patients aged 6 to 17 years who have not responded to conventional therapy including a corticosteroid an immunomodulator and primary nutrition therapy or who are intolerant to or have contraindications for such therapies. remicade has been studied only in combination with conventional immunosuppressive therapy -ankylosing spondylitis: remicade is indicated for: treatment of ankylosing spondylitis in patients who have severe axial symptoms elevated serological markers of inflammatory activity and who have responded inadequately to conventional ther

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined soya-bean oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - תחליב לאינפוזיה - glycine 5.67 g / 1000 ml; l- alanine 11.39 g / 1000 ml; l-histidine 2.64 g / 1000 ml; l-arginine 6.33 g / 1000 ml; l- methionine 2.20 g / 1000 ml; l- lysine as hydrochloride 3.19 g / 1000 ml; l- isoleucine 3.30 g / 1000 ml; l- threonine 2.31 g / 1000 ml; l- tryptophan 0.99 g / 1000 ml; l- proline 3.74 g / 1000 ml; l- phenylalanine 3.08 g / 1000 ml; l- valine 3.19 g / 1000 ml; l- tyrosine 0.22 g / 1000 ml; l- leucine 4.02 g / 1000 ml; l- serine 2.75 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 2.45 g / 1000 ml; refined soya-bean oil 100 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 200 g / 1000 ml; potassium chloride 2.98 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined soya-bean oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - תחליב לאינפוזיה - refined soya-bean oil 200.00 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 250.00 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 6.12 g / 1000 ml; l- valine 4.06 g / 1000 ml; l- tyrosine 0.28 g / 1000 ml; l- tryptophan 1.26 g / 1000 ml; l- threonine 2.94 g / 1000 ml; l- serine 3.50 g / 1000 ml; l- proline 4.76 g / 1000 ml; l- phenylalanine 3.92 g / 1000 ml; l- methionine 2.80 g / 1000 ml; l- lysine as hydrochloride 4.06 g / 1000 ml; l- leucine 5.11 g / 1000 ml; l- isoleucine 4.20 g / 1000 ml; l-histidine 3.36 g / 1000 ml; glycine 7.21 g / 1000 ml; l-arginine 8.05 g / 1000 ml; l- alanine 14.49 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined olive oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - תחליב לאינפוזיה - l- alanine 17.60 g / 1000 ml; refined olive oil 200 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 300 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 6.12 g / 1000 ml; l- valine 4.93 g / 1000 ml; l- tyrosine 0.34 g / 1000 ml; l- tryptophan 1.53 g / 1000 ml; l- threonine 3.57 g / 1000 ml; l- serine 4.25 g / 1000 ml; l- proline 5.78 g / 1000 ml; l- phenylalanine 4.76 g / 1000 ml; l- methionine 3.40 g / 1000 ml; l- lysine as hydrochloride 4.93 g / 1000 ml; l- leucine 6.21 g / 1000 ml; l- isoleucine 5.10 g / 1000 ml; l-histidine 4.08 g / 1000 ml; glycine 8.76 g / 1000 ml; l-arginine 9.78 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride; potassium chloride; refined soya-bean oil; sodium acetate dihydrate; sodium glycerophosphate - תחליב לאינפוזיה - refined soya-bean oil 200 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 4000.00 g / 1000 ml; magnesium chloride 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate 5.36 g / 1000 ml; sodium acetate dihydrate 6.12 g / 1000 ml; l- valine 5.80 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 1.80 g / 1000 ml; l- threonine 4.20 g / 1000 ml; l- serine 5.00 g / 1000 ml; l- proline 6.80 g / 1000 ml; l- phenylalanine 5.60 g / 1000 ml; l- methionine 4.00 g / 1000 ml; l- lysine as hydrochloride 5.80 g / 1000 ml; l- leucine 7.30 g / 1000 ml; l- isoleucine 6.00 g / 1000 ml; l-histidine 4.80 g / 1000 ml; glycine 10.30 g / 1000 ml; l-arginine 11.50 g / 1000 ml; l- alanine 20.70 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; refined soya-bean oil - תחליב לאינפוזיה - refined soya-bean oil 200 g / 1000 ml; glucose as monohydrate 400 g / 1000 ml; l- valine 5.80 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 1.80 g / 1000 ml; l- threonine 4.20 g / 1000 ml; l- serine 5.00 g / 1000 ml; l- proline 6.80 g / 1000 ml; l- phenylalanine 5.60 g / 1000 ml; l- methionine 4.00 g / 1000 ml; l- lysine as hydrochloride 5.80 g / 1000 ml; l- leucine 7.30 g / 1000 ml; l- isoleucine 6.00 g / 1000 ml; l-histidine 4.80 g / 1000 ml; glycine 10.30 g / 1000 ml; l-arginine 11.50 g / 1000 ml; l- alanine 20.70 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.